Meeting News CoverageVideo

VIDEO: Surgeon reports 2-year data on the COMPASS trial

MILAN — At the OSN Italy meeting, E. Randy Craven, MD, discusses minimally invasive glaucoma surgery focusing on the 2-year results of the COMPASS trial on the CyPass micro-stent from Transcend Medical, as well as methods of sustained IOP reduction with an implantable drug delivery system.

MILAN — At the OSN Italy meeting, E. Randy Craven, MD, discusses minimally invasive glaucoma surgery focusing on the 2-year results of the COMPASS trial on the CyPass micro-stent from Transcend Medical, as well as methods of sustained IOP reduction with an implantable drug delivery system.

    See more from OSN Italy Meeting